Rosiptor

Unassigned

New Medicines

Bladder pain syndrome / interstitial cystitis

Information

New molecular entity
Aquinox Pharmaceuticals
Aquinox Pharmaceuticals

Development and Regulatory status

Discontinued
Discontinued
Discontinued
Aug 18: Development discontinued [6].

Category

SH2-containing inositol phosphate 5-phosphatase (SHIP1) activator
Reliable data on the epidemiology of interstitial cystitis (preferred term now Bladder Pain Syndrome, BPS) are few, as robust diagnostic criteria are recent, but it is thought to affect at least 2% of women. It has a multifactorial aetiology, varying symptoms and variable prognosis, however it can have significant adverse effects on quality of life for those affected [2].
Bladder pain syndrome / interstitial cystitis
Oral